On November 12th, PW MEDTECH (01358) spent 1.034 million Hong Kong dollars to repurchase 1 million shares.
PwC Holdings Limited (01358) announced on November 12, 2024 that it will spend HK$103.4 million to repurchase its shares.
PW MEDTECH (01358) announced that on November 12, 2024, it will spend 1.034 million Hong Kong dollars to repurchase 1 million shares at a repurchase price of 1.03-1.04 Hong Kong dollars per share.
Related Articles

Neurocrine (NBIX.US) invests $2.9 billion to acquire Soleno (SLNO.US) to enter the field of metabolic diseases.

CMSC: By the middle to late April, the market focus will shift to industries with high growth in first quarter performance.

Ventilation and filtration system supplier Madison Air Solutions (MAIR.US) prices IPO at $25-27 per share, aiming to raise $2.23 billion.
Neurocrine (NBIX.US) invests $2.9 billion to acquire Soleno (SLNO.US) to enter the field of metabolic diseases.

CMSC: By the middle to late April, the market focus will shift to industries with high growth in first quarter performance.

Ventilation and filtration system supplier Madison Air Solutions (MAIR.US) prices IPO at $25-27 per share, aiming to raise $2.23 billion.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


